The Journal of Contemporary Dental Practice

Register      Login



Volume / Issue

Online First

Related articles

VOLUME 22 , ISSUE 1 ( January, 2021 ) > List of Articles


Local and Systemic Expression Profile of IL-10, IL-17, IL-27, IL-35, and IL-37 in Periodontal Diseases: A Cross-sectional Study

Jan Yang Ho, Bann Siang Yeo, Xiong Ling Yang, Theeban Thirugnanam, Mohammad Fakhrul Hakeem, Priyadarshi Soumyaranjan Sahu, Shaju Jacob Pulikkotil

Keywords : Cross-sectional study, Cytokine, Gingival crevicular fluid, Gingivitis, Interleukin, Periodontal disease, Periodontitis, plasma

Citation Information : Ho JY, Yeo BS, Yang XL, Thirugnanam T, Hakeem MF, Sahu PS, Pulikkotil S J. Local and Systemic Expression Profile of IL-10, IL-17, IL-27, IL-35, and IL-37 in Periodontal Diseases: A Cross-sectional Study. J Contemp Dent Pract 2021; 22 (1):73-79.

DOI: 10.5005/jp-journals-10024-3034

License: CC BY-NC 4.0

Published Online: 19-04-2021

Copyright Statement:  Copyright © 2021; The Author(s).


Aim: This study aimed to compare the level of interleukin (IL)-10, IL-17, IL-27, IL-35, and IL-37 in the gingival crevicular fluid (GCF) and human plasma of subjects with periodontal disease. Materials and methods: In this cross-sectional study conducted over a 3-month period at a primary dental clinic in Malaysia, 45 participants were recruited via consecutive sampling and assigned into three groups, namely healthy periodontium group (n = 15), gingivitis group (n = 15), and periodontitis group (n = 15). Gingival crevicular fluid and plasma samples were collected from each participant. Enzyme-linked immunosorbent assay test was conducted to measure the concentration of IL-10, IL-17, IL-27, IL-35, and IL-37. Kruskal–Wallis H test was used to compare the interleukin levels between patient groups. Results: In GCF samples, IL-17 level was the highest in the periodontitis group (p <0.05), while IL-27 was the lowest (p <0.05). Meanwhile, plasma levels of IL-27 and IL-37 were significantly lower (p <0.05) in the periodontitis group, but plasma IL-35 levels were observed to rise with increasing disease severity. Conclusion: There are reduced local and systemic levels of IL-27 in periodontitis patients. Clinical significance: Periodontal diseases exert both local and systemic effects, resulting in the destruction of the tooth-supporting structures and contributing to the systemic inflammatory burden. Some of the cytokines that were investigated in the current study, IL-17, IL-27, IL-35, and IL-37, can be potential biomarkers that warrant further longitudinal clinical studies to determine their usefulness as prognostic/diagnostic markers.

  1. Kassebaum NJ, Bernabé E, Dahiya M, et al. Global burden of severe periodontitis in 1990–2010: a systematic review and meta-regression. J Dent Res 2014;93(11):1045–1053. DOI: 10.1177/0022034514552491.
  2. Silva N, Abusleme L, Bravo D, et al. Host response mechanisms in periodontal diseases; 2015. Available from:
  3. Preshaw PM, Taylor JJ. How has research into cytokine interactions and their role in driving immune responses impacted our understanding of periodontitis? J Clin Periodontol 2011;38(Suppl. 1): 60–84. DOI: 10.1111/j.1600-051X.2010.01671.x.
  4. Bartold PM, Cantley MD, Haynes DR. Mechanisms and control of pathologic bone loss in periodontitis. Periodontol 2000 2010;53:55–69. DOI: 10.1111/j.1600-0757.2010.00347.x.
  5. Barros SP, Williams R, Offenbacher S, et al. Gingival crevicular fluid as a source of biomarkers for periodontitis. Periodontol 2000 2016;70(1):53–64. DOI: 10.1111/prd.12107.
  6. Kim J, Amar S. Periodontal disease and systemic conditions: a bidirectional relationship. Odontology 2006;94(1):10–21. DOI: 10.1007/s10266-006-0060-6.
  7. Vivar N, Van Vollenhoven RF. Advances in the treatment of rheumatoid arthritis. F1000Prime Rep 2014;6:31. DOI: 10.12703/P6-31.
  8. Hedrich CM, Bream JH. Cell type-specific regulation of IL-10 expression in inflammation and disease. Immunol Res 2010;47(1–3):185–206. DOI: 10.1007/s12026-009-8150-5.
  9. Iwasaki Y, Fujio K, Okamura T, et al. Interleukin-27 in T cell immunity. Int J Mol Sci 2015;16(2):2851–2863. DOI: 10.3390/ijms16022851.
  10. Neurath MF. IL-12 family members in experimental colitis. Mucosal Immunol [Internet] 2008;1(1):S28–S30. DOI: 10.1038/mi.2008.45.
  11. Dinarello CA. Overview of the IL-1 family in innate inflammation and acquired immunity. Immunol Rev 2018;281(1):8–27. DOI: 10.1111/imr.12621.
  12. Pan W, Wang Q, Chen Q. The cytokine network involved in the host immune response to periodontitis. Int J Oral Sci [Internet] 2019;11(3):30. DOI: 10.1038/s41368-019-0064-z.
  13. Kinney JS, Morelli T, Oh M, et al. Crevicular fluid biomarkers and periodontal disease progression. J Clin Periodontol 2014;41(2):113–120. DOI: 10.1111/jcpe.12194.
  14. Becerik S, Ozturk VO, Atmaca H, et al. Gingival crevicular fluid and plasma acute-phase cytokine levels in different periodontal diseases. J Periodontol VO [Internet] 2012;83(10):1304. Available from: DOI: 10.1902/jop.2012.110616.
  15. McGeachy MJ, Bak-Jensen KS, Chen Y, et al. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol 2007;8(12):1390–1397. DOI: 10.1038/ni1539.
  16. Iyer SS, Cheng G. Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Crit Rev Immunol 2012;32(1):23–63. DOI: 10.1615/critrevimmunol.v32.i1.30.
  17. Severino VO, Beghini M, de Araújo MF, et al. Expression of IL-6, IL-10, IL-17 and IL-33 in the peri-implant crevicular fluid of patients with peri-implant mucositis and peri-implantitis. Arch Oral Biol 2016;72:194–199. DOI: 10.1016/j.archoralbio.2016.08.021.
  18. Severino VO, Napimoga MH, De Lima Pereira SA. Expression of IL-6, IL-10, IL-17 and IL-8 in the peri-implant crevicular fluid of patients with peri-implantitis. Arch Oral Biol 2011;56(8):823–828. DOI: 10.1016/j.archoralbio.2011.01.006.
  19. Górska R, Gregorek H, Kowalski J, et al. Relationship between clinical parameters and cytokine profiles in inflamed gingival tissue and serum samples from patients with chronic periodontitis. J Clin Periodontol 2003;30(12):1046–1052. DOI: 10.1046/j.0303-6979.2003.00425.x.
  20. Cheng P, Qi X, Sun S, Liu L. [Study on the expression of IL-10 mRNA and the protein in gingival tissues of patients with chronic periodontitis]. Shanghai Kou Qiang Yi Xue 2005;14(3):284–288.
  21. Zenobia C, Hajishengallis G. Basic biology and role of interleukin-17 in immunity and inflammation. Periodontol 2000 2015;69(1):142–159. DOI: 10.1111/prd.12083.
  22. Garlet GP, Martins W, Ferreira BR, et al. Patterns of chemokines and chemokine receptors expression in different forms of human periodontal disease. J Periodontal Res 2003;38(2):210–217. DOI: 10.1034/j.1600-0765.2003.02012.x.
  23. Inönü E, Kayis SA, Eskan MA, et al. Salivary Del-1, IL-17, and LFA-1 levels in periodontal health and disease. J Periodontal Res 2020;55(4):511–518. DOI: 10.1111/jre.12738.
  24. Han J, Liu M, Jin Y, et al. [Comparison of the IL-27 level in gingival crevicular fluid of cross-quadrant and the upper and lower half-mouth subgingival scaling]. Shanghai Kou Qiang Yi Xue 2013;22(4):428–431. Available from:
  25. Babaloo A, Rahbar M, Babaloo Z, et al. Evaluation of clinical periodontal indices and serum interleukin-27 by one-stage full-mouth disinfection and quadrant scaling and root planing in periodontitis. J Contemp Dent Pract 2018;19(8):997–1004. DOI: 10.5005/jp-journals-10024-2372.
  26. Köseoğlu S, Sağlam M, Pekbağrıyanık T, et al. Level of interleukin-35 in gingival crevicular fluid, saliva and plasma in periodontal disease and health. J Periodontol 2015;86(8):1–12. DOI: 10.1902/jop.2015.140666.
  27. Mitani A, Niedbala W, Fujimura T, et al. Increased expression of interleukin (IL)-35 and IL-17, but not IL-27, in gingival tissues with chronic periodontitis. J Periodontol 2015;86(2):301–309. DOI: 10.1902/jop.2014.140293.
  28. Goodson JM, Tanner AC, Haffajee AD, et al. Patterns of progression and regression of advanced destructive periodontal disease. J Clin Periodontol 1982;9(6):472–481. DOI: 10.1111/j.1600-051x.1982.tb02108.x.
  29. Raj SC, Panda SM, Dash M, et al. Association of human interleukin-35 level in gingival crevicular fluid and serum in periodontal health, disease, and after nonsurgical therapy: a comparative study. Contemp Clin Dent 2018;9(2):293–297. DOI: 10.4103/ccd.ccd_51_18.
  30. Jin Y, Liu D, Lin X. IL-35 may maintain homeostasis of the immune microenvironment in periodontitis. Exp Ther Med 2017;14(6):5605–5610. DOI: 10.3892/etm.2017.5255.
  31. Sağlam M, Köseoğlu S, Savran L, et al. Levels of interleukin-37 in gingival crevicular fluid, saliva, or plasma in periodontal disease. J Periodontal Res 2015;50(5):614–621. DOI: 10.1111/jre.12241.
  32. Jia H, Liu J, Han B. Reviews of interleukin-37: functions, receptors, and roles in diseases. Biomed Res Int 2018;2018. DOI: 10.1155/2018/3058640.
  33. Tang R, Yi J, Yang J, et al. Interleukin-37 inhibits osteoclastogenesis and alleviates inflammatory bone destruction. J Cell Physiol 2019;234(5):7645–7658. DOI: 10.1002/jcp.27526.
  34. Zhao PW, Jiang WG, Wang L, et al. Plasma levels of IL-37 and correlation with TNF-α, IL-17A, and disease activity during DMARD treatment of rheumatoid arthritis. PLoS One 2014;9(5):e95346. DOI: 10.1371/journal.pone.0095346.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.